Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells
Charis E. Teh, Jianan Gong, David Segal, Tania Tan, Cassandra J. Vandenberg, Pasquale L. Fedele, Michael Löw, George Grigoriadis, Simon J. Harrison, Andreas Strasser, Andrew W. Roberts, David C.S. Huang, Garry P. Nolan, Daniel H.D. Gray, Melissa E. Ko
Topics & Concepts
BortezomibMultiple myelomaMass cytometryApoptosisCancer researchBone marrowMedicineProgrammed cell deathIn vivoDexamethasoneCancer cellBiologyCancerImmunologyInternal medicinePhenotypeGeneBiochemistryBiotechnologySingle-cell and spatial transcriptomicsImmune cells in cancerCancer Genomics and Diagnostics